Editor's note: The following press release comes from the WALTHAM company.
September 15, 2008 – The World Small Animal Veterinary Association and WALTHAM Centre for Pet Nutrition presented the 2008 International Award for Scientific Achievement to Peter Moore, BVSc, Ph.D., Professor, Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis during the association’s recent international conference in Dublin, Ireland.
The award, funded by WALTHAM, a division of Mars Inc., is presented annually to individuals who have had a “significant impact on the advancement of knowledge concerning the cause, detection, cure and/or control of disorders of companion animals.”
Dr. Moore was selected as a result of his pioneering work in the investigation and diagnosis of immune system neoplasia in dogs and cats. His work has been instrumental to the development of new diagnostic tests and treatment recommendations for dogs with lymphoma, leukemia, or histiocytic neoplasia. Histiocytic diseases, which include immuno-regulatory disorders and cancer, are most common in Bernese Mountain Dogs, Rottweilers, Flat Coated Retrievers, Golden Retrievers and sporadically in many other breeds. Histiocytic cancers remain difficult to treat despite the progress made in better diagnosis.
“I am pleased to have the opportunity to study immune system-related disorders in dogs at UC Davis. Although significant progress has been made, there remains a significant need for better education, earlier diagnosis, and enhanced treatment options for dogs with these diseases. I look forward to continuing my work in this area,” said Dr. Moore, who has created a Web site for dog owners and veterinarians to help answer questions about these disorders (http://www.histiocytosis.ucdavis.edu).
“Mars Corporation, which has funded the Scientific Achievement award for over 25 years, salutes Dr. Moore for his dedication to advancing the field of veterinary medicine, for his generosity in sharing his research findings with peers around the world, and for his willingness to translate his research into practical advice and support for dog owners and their veterinarians,” said Dr. Karyl J. Hurley, Global Scientific Affairs, WALTHAM.
Dr. Moore is respected by his colleagues for his research contributions, but also for his generosity in sharing the monoclonal reagents which his laboratory developed – long before these became commercially available. He has published his findings in more than 100 publications. Among these are numerous collaborative studies with veterinary colleagues worldwide in which the reagents he developed are applied to investigations of canine and feline diseases of the alimentary and respiratory tract, muscle and the central nervous system amongst others.
Click here to see another application of Dr. Moore's diagnostic methods: http://www.vetmed.ucdavis.edu/whatsnew/article.cfm?id=1640